Pendal Group LTD Regeneron Pharmaceuticals, Inc. Transaction History

Pendal Group LTD

$12.2 Billion
Q4 2022

A detailed history of Pendal Group LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Pendal Group LTD holds 118,417 shares of REGN stock, worth $123 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

118,417

Previous 111,766 5.95%

Holding current value

$123 Million

Previous $77 Million 10.97%

% of portfolio

0.7%

Previous 0.75%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 19, 2023	BUY	$705.89 - $766.39 $4.69 Million - $5.1 Million	6,651 Added 5.95%	118,417 $0
Q3 2022 Oct 18, 2022	SELL	$573.97 - $724.32 $27 Million - $34.1 Million	-47,013 Reduced 29.61%	111,766 $77 Million
Q2 2022 Jul 25, 2022	BUY	$548.35 - $738.84 $85.4 Million - $115 Million	155,795 Added 5221.01%	158,779 $93.9 Million
Q1 2022 Apr 25, 2022	SELL	$595.12 - $698.43 $1.35 Million - $1.58 Million	-2,262 Reduced 43.12%	2,984 $2.08 Million
Q4 2021 Jan 18, 2022	BUY	$543.48 - $670.97 $2.85 Million - $3.52 Million	5,246 New	5,246 $3.31 Million
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $291,607 - $345,927	-508 Closed	0 $0
Q2 2021 Jul 28, 2021	BUY	$472.8 - $558.54 $240,182 - $283,738	508 New	508 $284,000
Q4 2020 Jan 21, 2021	SELL	$478.3 - $607.98 $443,862 - $564,205	-928 Closed	0 $0
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $874,868 - $1.06 Million	-1,606 Reduced 63.38%	928 $519,000
Q2 2020 Aug 07, 2020	SELL	$493.32 - $643.92 $1.9 Million - $2.48 Million	-3,859 Reduced 60.36%	2,534 $1.58 Million
Q1 2020 May 04, 2020	BUY	$336.18 - $494.43 $937,269 - $1.38 Million	2,788 Added 77.34%	6,393 $3.12 Million
Q4 2019 Feb 06, 2020	BUY	$274.13 - $376.51 $837,193 - $1.15 Million	3,054 Added 554.26%	3,605 $1.35 Million
Q3 2019 Nov 12, 2019	SELL	$273.46 - $318.39 $935,780 - $1.09 Million	-3,422 Reduced 86.13%	551 $152,000
Q2 2019 Aug 01, 2019	BUY	$299.6 - $414.82 $1.19 Million - $1.65 Million	3,973 New	3,973 $0
Q2 2018 Jul 18, 2018	SELL	$284.6 - $344.99 $5.08 Million - $6.16 Million	-17,852 Closed	0 $0
Q1 2018 May 08, 2018	BUY	$315.82 - $393.78 $2.65 Million - $3.31 Million	8,396 Added 88.79%	17,852 $0
Q4 2017 Feb 06, 2018	BUY	$358.63 - $469.95 $3.34 Million - $4.37 Million	9,307 Added 6246.31%	9,456 $0
Q3 2017 Nov 01, 2017	BUY	$431.38 - $504.0 $64,275 - $75,096	149	149 $0

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Pendal Group LTD with notifications on news.

Account